The role involves leading a team to bring new antibody-drug conjugate projects into the portfolio and advancing them through pre-clinical development stages.
Base: $142,377.60 - $213,566.40 USD Annual; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program eligible; Benefits: Retirement contribution eligibility mentioned
Must-have
Nice-to-have
Not specified